Table 2

Mean (SD) values (range) of several serum S100B values, of the S100B area under the curve (AUC), and of the S100B peak value in n=23 patients with confirmed proximal middle cerebral artery occlusion (MCA/M1)

Early (<6 hrs) MCA/M1 recanalisation
S100B measurementObserved (n=7)Not observed (n=16)P*
*According to the modified Bonferroni correction (α adjustement), we used a p value of <0.0056 (0.05/9=0.0056) to indicate significant findings. †Occurrence of the S100B peak after stroke onset was not significantly different between groups (58.2 (25.7) h for recanalisation observed versus 77.8 (28.7) h for recanalisation not observed, p=0.19, Mann-Whitney U test).
Baseline (μg/l)0.10 (0.03) (0.05–0.14)0.15 (0.08) (0.06–0.36)0.089
8 h (μg/l)0.11 (0.02) (0.09–0.14)0.28 (0.38) (0.07–1.53)0.076
16 h (μg/l)0.19 (0.18) (0.07–0.58)1.20 (1.47) (0.07–4.71)0.039
24 h (μg/l)0.27 (0.34) (0.08–1.02)1.61 (1.59) (0.07–5.09)0.010
48 h (μg/l)0.37 (0.63) (0.07–1.79)3.49 (2.12) (0.71–6.84)<0.001*
72 h (μg/l)0.30 (0.40) (0.08–1.19)3.76 (2.43) (0.60–7.23)<0.001*
96 h (μg/l)0.24 (0.25) (0.09–0.81)4.42 (3.18) (0.50–9.46)<0.001*
AUC (μg/l/h)22.2 (40.1) (1.3–114.2)406.8 (284.4) (45.9–911.1)<0.001*
Peak (μg/l)†0.58 (0.99) (0.10–2.82)5.44 (3.61) (0.73–12.20)<0.001*